Skip to main content
Clinical Presentation of Coronavirus Disease 2019 (COVID-19) in Pregnant and Recently Pregnant People.
- Author(s): Afshar, Yalda;
- Gaw, Stephanie L;
- Flaherman, Valerie J;
- Chambers, Brittany D;
- Krakow, Deborah;
- Berghella, Vincenzo;
- Shamshirsaz, Alireza A;
- Boatin, Adeline A;
- Aldrovandi, Grace;
- Greiner, Andrea;
- Riley, Laura;
- Boscardin, W John;
- Jamieson, Denise J;
- Jacoby, Vanessa L;
- Pregnancy CoRonavIrus Outcomes RegIsTrY (PRIORITY) Study
- et al.
Published Web Locationhttps://doi.org/10.1097/aog.0000000000004178
ObjectiveTo describe the clinical presentation, symptomology, and disease course of coronavirus disease 2019 (COVID-19) in pregnancy.
MethodsThe PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) study is an ongoing nationwide prospective cohort study of people in the United States who are pregnant or up to 6 weeks postpregnancy with known or suspected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed the clinical presentation and disease course of COVID-19 in participants who tested positive for SARS-CoV-2 infection and reported symptoms at the time of testing.
ResultsOf 991 participants enrolled from March 22, 2020, until July 10, 2020, 736 had symptoms of COVID-19 at the time of testing; 594 tested positive for SARS-CoV-2 infection and 142 tested negative in this symptomatic group. Mean age was 31.3 years (SD 5.1), and 37% will nulliparous. Ninety-five percent were outpatients. Participants who tested positive for SARS-CoV-2-infection were a geographically diverse cohort: 34% from the Northeast, 25% from the West, 21% from the South, and 18% from the Midwest. Thirty-one percent of study participants were Latina, and 9% were Black. The average gestational age at enrollment was 24.1 weeks, and 13% of participants were enrolled after pregnancy. The most prevalent first symptoms in the cohort of patients who tested positive for SARS-CoV-2 infection were cough (20%), sore throat (16%), body aches (12%), and fever (12%). Median time to symptom resolution was 37 days (95% CI 35-39). One quarter (25%) of participants who tested positive for SARS-CoV-2 infection had persistent symptoms 8 or more weeks after symptom onset.
ConclusionCOVID-19 has a prolonged and nonspecific disease course during pregnancy and in the 6 weeks after pregnancy.
Clinical trial registrationClinicalTrials.gov, NCT04323839.
For improved accessibility of PDF content, download the file to your device.